Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Omixon Releases Omixon Target for NGS Data Analysis

Published: Thursday, May 31, 2012
Last Updated: Wednesday, May 30, 2012
Bookmark and Share
Next generation sequencing analysis software for targeted sequencing.

Omixon has announced the commercial release of Omixon Target, a next generation sequencing analysis software for targeted sequencing.

Omixon built its new software Target with the vision of helping diagnostic labs to adopt next generation sequencing to replace and complement traditional capillary Sanger sequencing.

Target was built “with diagnostics in mind” explains Tim Hague, CTO of Omixon.”It is built for precision and it is undergoing various levels of validation.

This is the first NGS tool to introduce analysis quality control based on repeat analysis with mutated reference as well as with simulated short reads. This gives a realistic indication of false discovery rates for the given target.”

"We are using next-generation sequencing techniques to advance patient care at Almac and we know that accurate data and meaningful data interpretation are dependent upon employing the best analysis tools and techniques,” said Gavin Oliver, bioinformatics team leader at Almac.

Oliver continued, “Omixon fully understand this requirement and are creating highly-tuned software solutions that will empower scientists by removing much of the uncertainty from these complex analyses."

CEO of Omixon, Attila Berces, adds: " Targeted, or amplicon based sequencing is the method of choice for diagnosing several genetic disorders, screening for hereditary mutations of disease susceptibility genes or matching donors and recipients of organ transplants. These targeted amplicons are increasingly sequenced by next generation sequencing. Each diagnostic target presents different analysis challenges from a computational standpoint. The sensitive detection of long insertions and deletions is crucial for several oncogenes, while the immune system related genes show orders of higher genetic diversity. Omixon Target uses profiles with parameters set up for the particular gene target, which guaranties the highest possible precision for diverse situation."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
New Diagnostic Tool for Familial Mediterranean Fever
A new tool developed by researchers at VIB and Ghent University could improve the process of diagnosing Familial Mediterranean Fever.
'Lab on the Skin' for Sweat Analysis
Northwestern University researchers develop a low-cost wearable electronic device that collects and analyzes sweat for health monitoring.
Molecular Signature for Aggressive Brain Tumor Uncovered
Researchers have identified genetic mutations in a highly agressive brain cancer that distinguishes the agressive, from the benign forms of the cancer.
Malaria Parasite Evades Rapid Test Detection in Children
A study at the University of North Carolina found that gene deletion poses a threat to Malaria eradication efforts.
Novel Urine Test to Predict High-Risk Cervical Cancer
Preliminary studies affirm accuracy and potential cost savings to screen for virus-caused malignancy.
GFC Diagnostics Wins Longitude Prize Discovery Award
The global award was won for the development of a cheap, quick and simple MRSA Test.
Understanding Circulating Tumour Cells
Research team develops new tool to track traveling cancer cells in the bloodstream.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!